NCT04262466 2026-03-06Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint InhibitorsImmunocore LtdPhase 1/2 Active not recruiting410 enrolled
NCT02153229 2025-12-26MPM-PDTAbramson Cancer Center at Penn MedicinePhase 2 Active not recruiting52 enrolled
NCT04185883 2025-10-22Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)AmgenPhase 1 Active not recruiting610 enrolled